Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Trial register facet

Trial records for GHK-Cu

10 records for GHK-Cu, of which 2 are published trials.

Showing 0 records on this page

Records

10 documents

Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.

RecordCompoundPhaseStatusDesignRandomisedYearCertainty
GHKCU-TOPICAL-2GHK-CuPhase 2ReportedRandomised, double-blind, placebo-controlled2007Low
GHKCU-TOPICAL-2-HEPATIC-IMPprogramme recordGHK-CuPhase 1ReportedPhase 1 ascending dose2007Very low
GHKCU-TOPICAL-2-DDIprogramme recordGHK-CuPhase 1ReportedRandomised crossover2007Very low
GHKCU-TOPICAL-2-PKprogramme recordGHK-CuPhase 1ReportedPhase 1 ascending dose2007Very low
GHKCU-TOPICAL-2-RENAL-IMPprogramme recordGHK-CuPhase 1ReportedPhase 1 ascending dose2007Very low
GHKCU-TOPICAL-1GHK-CuPhase 2ReportedRandomised, double-blind, placebo-controlled2005Low
GHKCU-TOPICAL-1-RENAL-IMPprogramme recordGHK-CuPhase 1ReportedPhase 1 ascending dose2005Very low
GHKCU-TOPICAL-1-PKprogramme recordGHK-CuPhase 1ReportedPhase 1 ascending dose2005Very low
GHKCU-TOPICAL-1-DDIprogramme recordGHK-CuPhase 1ReportedRandomised crossover2005Very low
GHKCU-TOPICAL-1-HEPATIC-IMPprogramme recordGHK-CuPhase 1ReportedPhase 1 ascending dose2005Very low
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.